BioWorld MedTech

Jan. 27, 2016

View Archived Issues

Firm finds niche in cardiovascular monitoring: Irhythm finds its groove in both wearable, digital health markets

Read More

Hold placed on Califf nomination: Senate hostage-taking snares confirmation of FDA head

Read More

Ebola Lessons learned? Global organizations to speed Zika R&D

Read More

Financings: Minnetronix dips its toe in equity market with $20M raise

Read More

People in Places

Read More

Daily M&A: Perkinelmer completes acquisition of Vanadis

Read More

Agreements/contracts: Stereotaxis, Philips to continue cardiology procedure work

Read More

product briefs

Read More

Briefly noted

Read More

MDD's Oncology Extra

Read More

Funding to be used for host of trials: Cancer genomics firm Inivata pulls in $42M in series A funding

LONDON – Inivata Ltd. has raised £31.5 million (US$42.2 million) in a series A round, to advance the commercialization of its circulating tumor DNA liquid biopsy technology. Read More

Inside the Beltway: NICE offers favorable review of AMS's Greenlight for BPH

Read More